IQuity is a research organization developing the next generation of blood-based, genomic tests to detect and monitor autoimmune disease. IQuity continues to build an intellectual property portfolio focused on detecting and monitoring autoimmune disease. IQuity commercialized three genomic tests for multiple sclerosis, IBS versus Crohn's and ulcerative colitis, and fibromyalgia syndrome. IQuity has transitioned from a commercial laboratory to a pure R&D organization that continues to receive NIH/SBIR grant funding.